In a new study, researchers at the University of Vermont developed a set of synthetic molecules that can successfully…
Articles by Margarida Azevedo, MSc
Researchers found that key immune cells, called regulatory T lymphocytes (Treg), are dysfunctional in all forms of pulmonary arterial hypertension…
Actelion Ltd. was recently recognized for its work in the treatment of rare diseases with the the EURORDIS Company Award 2016,…
Researchers at University College London (UCL) and Actelion Pharmaceuticals presented a study investigating the therapeutic effect of macitentan…
Researchers at the Baskent University Faculty of Medicine in Turkey recently provided an overview of the existing literature regarding portopulmonary…
In a new study, researchers used novel cardiovascular magnetic resonance (CMR) tissue phase mapping (TPM) to determine if right ventricular…
Bellerophon Therapeutics recently announced results from the final analysis of the second part of its Phase 2 clinical trial evaluating INOpulse for…
Clinical-stage biotherapeutics company, Bellerophon Therapeutics, Inc., recently announced that its proprietary program device, a new version of the INOpulse drug-device delivery…
Researchers at the National University of Singapore (NUS) and the Agency for Science, Technology and Research (A*STAR) have developed an…
According to a recent announcement, the United States Food and Drug Administration (FDA) approved Actelion Pharmaceuticals’ Uptravi (selexipag) tablets…
Researchers have developed a computer tomography pulmonary embolism residua index (CTPER-index) that may prove to be a useful tool for diagnosis…
In a new study, researchers observed that intrapulmonary vascular dilatations (IPVDs), essential features of hepatopulmonary syndrome (HPS), were more commonly…